Johns Hopkins researchers have identified a WIF1-expressing basal epithelial cell type concentrated in the prostate's ...
Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results